69 related articles for article (PubMed ID: 3431592)
1. Cisplatin and dichloromethotrexate: a pharmacologically rational combination.
Natale RB; Wheeler RH; Roberts JA
NCI Monogr; 1987; (5):219-23. PubMed ID: 3431592
[TBL] [Abstract][Full Text] [Related]
2. A phase I-II trial of cisplatin and dichloromethotrexate in squamous cell cancer of the head and neck.
Wheeler RH; Natale RB; Roshon SG; Baker SR
J Clin Oncol; 1984 Jul; 2(7):831-5. PubMed ID: 6539813
[TBL] [Abstract][Full Text] [Related]
3. Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin.
Laurie SA; Pfister DG; Kris MG; Tong WP; Chronowski G; Pisters KM; Heelan RT; Sirotnak FM
Clin Cancer Res; 2001 Mar; 7(3):501-9. PubMed ID: 11297240
[TBL] [Abstract][Full Text] [Related]
4. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
[TBL] [Abstract][Full Text] [Related]
6. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
[TBL] [Abstract][Full Text] [Related]
7. Salvage chemotherapy with PEM and long-CF regimen in CDDP refractory advanced head and neck cancer.
Kohno N; Ichikawa G; Shirasaka T; Inuyama Y; Kawaida M; Ohnuma T
Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():209-14. PubMed ID: 7661582
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
9. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Katori H; Tsukuda M; Taguchi T
Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
[TBL] [Abstract][Full Text] [Related]
10. [Low-dose CDDP and 5-FU for head and neck cancer patients].
Fujii M; Kanke M; Tomita T
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1542-7. PubMed ID: 10553410
[TBL] [Abstract][Full Text] [Related]
11. [High dose methotrexate with CF rescue therapy in patients with head and neck cancer].
Inuyama Y; Taketa C; Hiroto I; Fujii M; Takaoka T; Tanaka J; Matsuura S; Satake B; Takeoda S; Nishijima W
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1823-31. PubMed ID: 6332576
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck.
Hussain M; Gadgeel S; Kucuk O; Du W; Salwen W; Ensley J
Cancer; 1999 Dec; 86(11):2364-9. PubMed ID: 10590379
[TBL] [Abstract][Full Text] [Related]
13. [Head and neck cancer].
Inuyama Y; Fukuda S; Fujii M; Tanaka K; Kawaura M; Kawasaki K; Kohno N
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1136-42. PubMed ID: 8751800
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel, cisplatin and methotrexate combination chemotherapy is active in the treatment of refractory urothelial malignancies.
Tu SM; Hossan E; Amato R; Kilbourn R; Logothetis CJ
J Urol; 1995 Nov; 154(5):1719-22. PubMed ID: 7563331
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: a preliminary report.
Hussain M; Salwen W; Kucuk O; Ensley J
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-43-S19-45. PubMed ID: 9427265
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study of neoadjuvant intraarterial chemotherapy (I A-MAC) for advanced bladder cancer].
Takahashi Y; Deguchi T; Kuriyama M; Nakano M; Ueno K; Shinoda I; Takeda A; Itoh S; Doi T; Takeuchi T
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2311-4. PubMed ID: 7944467
[TBL] [Abstract][Full Text] [Related]
18. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial between two neoadjuvant chemotherapy protocols: CDDP + 5-FU versus CDDP + VP16 in advanced cancer of the head and neck.
Prévost A; Mérol JC; Aimé P; Moutel K; Roger-Liautaud F; Nasca S; Legros M; Coninx P
Oncol Rep; 2005 Sep; 14(3):771-6. PubMed ID: 16077990
[TBL] [Abstract][Full Text] [Related]
20. Multidrug chemotherapy using bleomycin, methotrexate, and cisplatin alone or combined with radiotherapy in advanced head and neck cancer.
Kuten A; Zidan J; Cohen Y; Robinson E
Cancer Treat Rep; 1983 Jun; 67(6):573-4. PubMed ID: 6190559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
